{"entity":{"type":"insider","cik":"0001504466","url":"/insider/0001504466","json_url":"/insider/0001504466.json","name":"Maples Kirk R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":63,"n_filings":46,"first":"2011-05-26","last":"2015-06-02","span_basis":"filed_date"},"name_variants":[{"name":"Maples Kirk R","source":"filing","n_filings":46,"first_seen":"2011-05-26","last_seen":"2015-06-02"}],"transactions":[{"id":8793385,"accession":"0001209191-15-049207","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-049207","line_url":"/filing/0001209191-15-049207#line-2","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":70.0316,"price_display":"70.03","price_state":"stated","total_value":35015.8,"total_display":"35,015.80","shares_owned_after":7320.0,"shares_owned_after_display":"7,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-02","scope":"insider"},{"id":8793384,"accession":"0001209191-15-049207","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-049207","line_url":"/filing/0001209191-15-049207#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":71.72,"price_display":"71.72","price_state":"stated","total_value":7172.0,"total_display":"7,172.00","shares_owned_after":7220.0,"shares_owned_after_display":"7,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-02","scope":"insider"},{"id":8942629,"accession":"0001209191-15-043018","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-043018","line_url":"/filing/0001209191-15-043018#line-3","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4900.0,"shares_display":"4,900","price_per_share":60.9695,"price_display":"60.97","price_state":"stated","total_value":298750.55,"total_display":"298,750.55","shares_owned_after":8980.0,"shares_owned_after_display":"8,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-12","filed_date":"2015-05-14","scope":"insider"},{"id":8942627,"accession":"0001209191-15-043018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-043018","line_url":"/filing/0001209191-15-043018#line-2","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1160.0,"shares_display":"1,160","price_per_share":61.4966,"price_display":"61.50","price_state":"stated","total_value":71336.056,"total_display":"71,336.06","shares_owned_after":7820.0,"shares_owned_after_display":"7,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-12","filed_date":"2015-05-14","scope":"insider"},{"id":8938516,"accession":"0001209191-15-038191","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-038191","line_url":"/filing/0001209191-15-038191#line-2","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":54.142,"price_display":"54.14","price_state":"stated","total_value":27071.0,"total_display":"27,071.00","shares_owned_after":7820.0,"shares_owned_after_display":"7,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-01","filed_date":"2015-05-01","scope":"insider"},{"id":8938514,"accession":"0001209191-15-038191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-038191","line_url":"/filing/0001209191-15-038191#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":52.99,"price_display":"52.99","price_state":"stated","total_value":5299.0,"total_display":"5,299.00","shares_owned_after":8320.0,"shares_owned_after_display":"8,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-01","filed_date":"2015-05-01","scope":"insider"},{"id":8126782,"accession":"0001209191-15-032245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-032245","line_url":"/filing/0001209191-15-032245#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":57.015,"price_display":"57.02","price_state":"stated","total_value":34209.0,"total_display":"34,209.00","shares_owned_after":8420.0,"shares_owned_after_display":"8,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-01","filed_date":"2015-04-03","scope":"insider"},{"id":8802239,"accession":"0001209191-15-022570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-022570","line_url":"/filing/0001209191-15-022570#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":43.9483,"price_display":"43.95","price_state":"stated","total_value":26368.98,"total_display":"26,368.98","shares_owned_after":9020.0,"shares_owned_after_display":"9,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-04","scope":"insider"},{"id":8237931,"accession":"0001209191-15-009386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-009386","line_url":"/filing/0001209191-15-009386#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":37.4133,"price_display":"37.41","price_state":"stated","total_value":22447.98,"total_display":"22,447.98","shares_owned_after":4600.0,"shares_owned_after_display":"4,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-02","filed_date":"2015-02-04","scope":"insider"},{"id":8456311,"accession":"0001209191-15-002191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-002191","line_url":"/filing/0001209191-15-002191#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":31.9567,"price_display":"31.96","price_state":"stated","total_value":19174.02,"total_display":"19,174.02","shares_owned_after":4200.0,"shares_owned_after_display":"4,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-06","scope":"insider"},{"id":6323434,"accession":"0001209191-14-074300","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-074300","line_url":"/filing/0001209191-14-074300#line-4","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40104.0,"shares_display":"40,104","price_per_share":36.5234,"price_display":"36.52","price_state":"stated","total_value":1464734.4336,"total_display":"1,464,734.43","shares_owned_after":4800.0,"shares_owned_after_display":"4,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-09","filed_date":"2014-12-10","scope":"insider"},{"id":6323432,"accession":"0001209191-14-074300","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-074300","line_url":"/filing/0001209191-14-074300#line-3","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19896.0,"shares_display":"19,896","price_per_share":36.5234,"price_display":"36.52","price_state":"stated","total_value":726669.5664,"total_display":"726,669.57","shares_owned_after":4800.0,"shares_owned_after_display":"4,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-09","filed_date":"2014-12-10","scope":"insider"},{"id":6272620,"accession":"0001209191-14-072886","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-072886","line_url":"/filing/0001209191-14-072886#line-2","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":33.245,"price_display":"33.24","price_state":"stated","total_value":16622.5,"total_display":"16,622.50","shares_owned_after":4900.0,"shares_owned_after_display":"4,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-03","scope":"insider"},{"id":6272618,"accession":"0001209191-14-072886","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-072886","line_url":"/filing/0001209191-14-072886#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":34.03,"price_display":"34.03","price_state":"stated","total_value":3403.0,"total_display":"3,403.00","shares_owned_after":4800.0,"shares_owned_after_display":"4,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-03","scope":"insider"},{"id":7003102,"accession":"0001209191-14-066396","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-066396","line_url":"/filing/0001209191-14-066396#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":29.095,"price_display":"29.10","price_state":"stated","total_value":17457.0,"total_display":"17,457.00","shares_owned_after":5400.0,"shares_owned_after_display":"5,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-04","scope":"insider"},{"id":6949909,"accession":"0001209191-14-061056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-061056","line_url":"/filing/0001209191-14-061056#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":23.8533,"price_display":"23.85","price_state":"stated","total_value":14311.98,"total_display":"14,311.98","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-02","scope":"insider"},{"id":6355019,"accession":"0001209191-14-055930","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-14-055930","line_url":"/filing/0001209191-14-055930#line-7","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22325.0,"shares_display":"22,325","price_per_share":23.2971,"price_display":"23.30","price_state":"stated","total_value":520107.7575,"total_display":"520,107.76","shares_owned_after":8294.0,"shares_owned_after_display":"8,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6355017,"accession":"0001209191-14-055930","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-14-055930","line_url":"/filing/0001209191-14-055930#line-6","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9860.0,"shares_display":"9,860","price_per_share":23.2971,"price_display":"23.30","price_state":"stated","total_value":229709.406,"total_display":"229,709.41","shares_owned_after":8294.0,"shares_owned_after_display":"8,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6355015,"accession":"0001209191-14-055930","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-055930","line_url":"/filing/0001209191-14-055930#line-5","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":23.335,"price_display":"23.34","price_state":"stated","total_value":23335.0,"total_display":"23,335.00","shares_owned_after":7294.0,"shares_owned_after_display":"7,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6355014,"accession":"0001209191-14-055930","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-055930","line_url":"/filing/0001209191-14-055930#line-4","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":23.315,"price_display":"23.32","price_state":"stated","total_value":13989.0,"total_display":"13,989.00","shares_owned_after":6600.0,"shares_owned_after_display":"6,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6355011,"accession":"0001209191-14-055930","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-055930","line_url":"/filing/0001209191-14-055930#line-3","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94.0,"shares_display":"94","price_per_share":23.34,"price_display":"23.34","price_state":"stated","total_value":2193.96,"total_display":"2,193.96","shares_owned_after":7200.0,"shares_owned_after_display":"7,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6973448,"accession":"0001209191-14-052699","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-052699","line_url":"/filing/0001209191-14-052699#line-4","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3592.0,"shares_display":"3,592","price_per_share":19.9575,"price_display":"19.96","price_state":"stated","total_value":71687.34,"total_display":"71,687.34","shares_owned_after":8294.0,"shares_owned_after_display":"8,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-13","filed_date":"2014-08-15","scope":"insider"},{"id":6973445,"accession":"0001209191-14-052699","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-052699","line_url":"/filing/0001209191-14-052699#line-3","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":367.0,"shares_display":"367","price_per_share":19.9575,"price_display":"19.96","price_state":"stated","total_value":7324.4025,"total_display":"7,324.40","shares_owned_after":1633.0,"shares_owned_after_display":"1,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-13","filed_date":"2014-08-15","scope":"insider"},{"id":6763671,"accession":"0001209191-14-039606","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-039606","line_url":"/filing/0001209191-14-039606#line-2","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":14.7281,"price_display":"14.73","price_state":"stated","total_value":14728.1,"total_display":"14,728.10","shares_owned_after":620.0,"shares_owned_after_display":"620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-04","filed_date":"2014-06-06","scope":"insider"},{"id":6763667,"accession":"0001209191-14-039606","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-039606","line_url":"/filing/0001209191-14-039606#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":620.0,"shares_display":"620","price_per_share":14.6491,"price_display":"14.65","price_state":"stated","total_value":9082.442,"total_display":"9,082.44","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-04","filed_date":"2014-06-06","scope":"insider"},{"id":6614715,"accession":"0001209191-14-036214","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-036214","line_url":"/filing/0001209191-14-036214#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":14.154,"price_display":"14.15","price_state":"stated","total_value":21231.0,"total_display":"21,231.00","shares_owned_after":1620.0,"shares_owned_after_display":"1,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-20","filed_date":"2014-05-22","scope":"insider"},{"id":6999999,"accession":"0001209191-14-028694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-028694","line_url":"/filing/0001209191-14-028694#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":15.5978,"price_display":"15.60","price_state":"stated","total_value":23396.7,"total_display":"23,396.70","shares_owned_after":3120.0,"shares_owned_after_display":"3,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-21","filed_date":"2014-04-22","scope":"insider"},{"id":7092822,"accession":"0001209191-14-022770","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-022770","line_url":"/filing/0001209191-14-022770#line-2","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2381.0,"shares_display":"2,381","price_per_share":22.2887,"price_display":"22.29","price_state":"stated","total_value":53069.3947,"total_display":"53,069.39","shares_owned_after":5239.0,"shares_owned_after_display":"5,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-20","filed_date":"2014-03-24","scope":"insider"},{"id":7092821,"accession":"0001209191-14-022770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-022770","line_url":"/filing/0001209191-14-022770#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":619.0,"shares_display":"619","price_per_share":22.7705,"price_display":"22.77","price_state":"stated","total_value":14094.9395,"total_display":"14,094.94","shares_owned_after":4620.0,"shares_owned_after_display":"4,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-20","filed_date":"2014-03-24","scope":"insider"},{"id":6491828,"accession":"0001209191-14-013250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-013250","line_url":"/filing/0001209191-14-013250#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":19.3257,"price_display":"19.33","price_state":"stated","total_value":57977.1,"total_display":"57,977.10","shares_owned_after":7620.0,"shares_owned_after_display":"7,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-20","filed_date":"2014-02-21","scope":"insider"},{"id":6994178,"accession":"0001209191-14-004284","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-004284","line_url":"/filing/0001209191-14-004284#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":20.2747,"price_display":"20.27","price_state":"stated","total_value":60824.1,"total_display":"60,824.10","shares_owned_after":9620.0,"shares_owned_after_display":"9,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-21","filed_date":"2014-01-22","scope":"insider"},{"id":5453828,"accession":"0001209191-13-058572","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-058572","line_url":"/filing/0001209191-13-058572#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":16.7263,"price_display":"16.73","price_state":"stated","total_value":50178.9,"total_display":"50,178.90","shares_owned_after":12620.0,"shares_owned_after_display":"12,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-20","filed_date":"2013-12-24","scope":"insider"},{"id":5041558,"accession":"0001209191-13-040786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-040786","line_url":"/filing/0001209191-13-040786#line-2","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.7102,"price_display":"9.71","price_state":"stated","total_value":9710.2,"total_display":"9,710.20","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-14","filed_date":"2013-08-14","scope":"insider"},{"id":5041554,"accession":"0001209191-13-040786","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-040786","line_url":"/filing/0001209191-13-040786#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52.0,"shares_display":"52","price_per_share":9.73,"price_display":"9.73","price_state":"stated","total_value":505.96,"total_display":"505.96","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-14","filed_date":"2013-08-14","scope":"insider"},{"id":4504833,"accession":"0001209191-13-032339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-032339","line_url":"/filing/0001209191-13-032339#line-2","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":5.3911,"price_display":"5.39","price_state":"stated","total_value":21564.4,"total_display":"21,564.40","shares_owned_after":1652.0,"shares_owned_after_display":"1,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-06-14","scope":"insider"},{"id":4504825,"accession":"0001209191-13-032339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-032339","line_url":"/filing/0001209191-13-032339#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":5.391,"price_display":"5.39","price_state":"stated","total_value":8625.6,"total_display":"8,625.60","shares_owned_after":52.0,"shares_owned_after_display":"52","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-06-14","scope":"insider"},{"id":2412098,"accession":"0001209191-12-054655","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-054655","line_url":"/filing/0001209191-12-054655#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":5.2219,"price_display":"5.22","price_state":"stated","total_value":15665.7,"total_display":"15,665.70","shares_owned_after":4652.0,"shares_owned_after_display":"4,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-26","filed_date":"2012-11-27","scope":"insider"},{"id":2919996,"accession":"0001209191-12-051452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-051452","line_url":"/filing/0001209191-12-051452#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":5.81,"price_display":"5.81","price_state":"stated","total_value":17430.0,"total_display":"17,430.00","shares_owned_after":7652.0,"shares_owned_after_display":"7,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-01","filed_date":"2012-11-02","scope":"insider"},{"id":3191403,"accession":"0001209191-12-046626","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-046626","line_url":"/filing/0001209191-12-046626#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":6.5546,"price_display":"6.55","price_state":"stated","total_value":19663.8,"total_display":"19,663.80","shares_owned_after":10652.0,"shares_owned_after_display":"10,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-24","filed_date":"2012-09-25","scope":"insider"},{"id":3398649,"accession":"0001209191-12-043382","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-043382","line_url":"/filing/0001209191-12-043382#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":6.1657,"price_display":"6.17","price_state":"stated","total_value":18497.1,"total_display":"18,497.10","shares_owned_after":13652.0,"shares_owned_after_display":"13,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-27","filed_date":"2012-08-28","scope":"insider"},{"id":9268374,"accession":"0001209191-12-046623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-046623","line_url":"/filing/0001209191-12-046623#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":6.0289,"price_display":"6.03","price_state":"stated","total_value":18086.7,"total_display":"18,086.70","shares_owned_after":15652.0,"shares_owned_after_display":"15,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-30","filed_date":"2012-09-25","scope":"insider"},{"id":3278688,"accession":"0001104659-12-053181","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-053181","line_url":"/filing/0001104659-12-053181#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":6.0289,"price_display":"6.03","price_state":"stated","total_value":18086.7,"total_display":"18,086.70","shares_owned_after":15652.0,"shares_owned_after_display":"15,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-30","filed_date":"2012-08-01","scope":"insider"},{"id":3513151,"accession":"0001104659-12-046208","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-046208","line_url":"/filing/0001104659-12-046208#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":5.44,"price_display":"5.44","price_state":"stated","total_value":16320.0,"total_display":"16,320.00","shares_owned_after":18652.0,"shares_owned_after_display":"18,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-25","filed_date":"2012-06-27","scope":"insider"},{"id":3409468,"accession":"0001104659-12-040725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-040725","line_url":"/filing/0001104659-12-040725#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":5.3417,"price_display":"5.34","price_state":"stated","total_value":16025.1,"total_display":"16,025.10","shares_owned_after":21652.0,"shares_owned_after_display":"21,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-29","filed_date":"2012-05-30","scope":"insider"},{"id":3162142,"accession":"0001104659-12-027765","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-027765","line_url":"/filing/0001104659-12-027765#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":5.4627,"price_display":"5.46","price_state":"stated","total_value":16388.1,"total_display":"16,388.10","shares_owned_after":24652.0,"shares_owned_after_display":"24,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-23","filed_date":"2012-04-24","scope":"insider"},{"id":2084545,"accession":"0001104659-12-021346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-021346","line_url":"/filing/0001104659-12-021346#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":6.4472,"price_display":"6.45","price_state":"stated","total_value":19341.6,"total_display":"19,341.60","shares_owned_after":27652.0,"shares_owned_after_display":"27,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-26","filed_date":"2012-03-27","scope":"insider"},{"id":3409350,"accession":"0001104659-12-014119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-014119","line_url":"/filing/0001104659-12-014119#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":5.898,"price_display":"5.90","price_state":"stated","total_value":17694.0,"total_display":"17,694.00","shares_owned_after":30652.0,"shares_owned_after_display":"30,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-27","filed_date":"2012-02-28","scope":"insider"},{"id":3055087,"accession":"0001104659-12-005406","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-005406","line_url":"/filing/0001104659-12-005406#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":7.1145,"price_display":"7.11","price_state":"stated","total_value":21343.5,"total_display":"21,343.50","shares_owned_after":31652.0,"shares_owned_after_display":"31,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-30","filed_date":"2012-01-31","scope":"insider"},{"id":3512956,"accession":"0001104659-12-001648","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-001648","line_url":"/filing/0001104659-12-001648#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (SVP, Program Management)","officer_title":"SVP, Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":5.4838,"price_display":"5.48","price_state":"stated","total_value":16451.4,"total_display":"16,451.40","shares_owned_after":34652.0,"shares_owned_after_display":"34,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-10","filed_date":"2012-01-11","scope":"insider"},{"id":2541261,"accession":"0001104659-12-001129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-001129","line_url":"/filing/0001104659-12-001129#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001504466","owner_name":"Maples Kirk R","owner_url":"/insider/0001504466","role":"Officer (S.V.P., Program Management)","officer_title":"S.V.P., Program Management","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":6.145,"price_display":"6.14","price_state":"stated","total_value":61450.0,"total_display":"61,450.00","shares_owned_after":37652.0,"shares_owned_after_display":"37,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-30","filed_date":"2012-01-09","scope":"insider"}],"next_cursor":"2011-12-30|2541261","ledger_fault":false,"count":{"value":63,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":63,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":63},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001411158","name":"Anacor Pharmaceuticals, Inc.","url":"/issuer/0001411158","role":"Officer (SVP, Program Management)","n_filings":46,"first_seen":"2011-05-26","last_seen":"2015-06-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001504466","retrieved_at":"2026-08-21T11:36:40+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}